Evaluating the Methylphenidate Patch to Treat Former Stimulant Users With ADHD
Status:
Completed
Trial end date:
2009-02-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the effectiveness and safety of Daytrana® in the
treatment of attention deficit hyperactivity disorder (ADHD) in adults who have abused
stimulants in the past. Daytrana® is a stimulant medication that has been approved by the
Food and Drug Administration for the treatment of ADHD in children over the age of 6 years
old.